KR20210057596A - 해양심층수와 표고버섯 추출액을 유효성분으로 함유하는 화장료 조성물 및 이의 제조방법 - Google Patents
해양심층수와 표고버섯 추출액을 유효성분으로 함유하는 화장료 조성물 및 이의 제조방법 Download PDFInfo
- Publication number
- KR20210057596A KR20210057596A KR1020190144547A KR20190144547A KR20210057596A KR 20210057596 A KR20210057596 A KR 20210057596A KR 1020190144547 A KR1020190144547 A KR 1020190144547A KR 20190144547 A KR20190144547 A KR 20190144547A KR 20210057596 A KR20210057596 A KR 20210057596A
- Authority
- KR
- South Korea
- Prior art keywords
- water
- cosmetic composition
- extract
- concentrated
- skin
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 163
- 240000000599 Lentinula edodes Species 0.000 title claims abstract description 83
- 239000002537 cosmetic Substances 0.000 title claims abstract description 78
- 239000000203 mixture Substances 0.000 title claims abstract description 72
- 239000000284 extract Substances 0.000 title claims abstract description 66
- 235000001715 Lentinula edodes Nutrition 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 239000004480 active ingredient Substances 0.000 title description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 58
- 239000011707 mineral Substances 0.000 claims abstract description 58
- 239000013535 sea water Substances 0.000 claims abstract description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 58
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 48
- 238000002156 mixing Methods 0.000 claims description 26
- 238000001035 drying Methods 0.000 claims description 24
- 150000001450 anions Chemical class 0.000 claims description 13
- 238000001704 evaporation Methods 0.000 claims description 13
- 239000004744 fabric Substances 0.000 claims description 13
- 238000003809 water extraction Methods 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 12
- 230000008020 evaporation Effects 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 11
- 108091005804 Peptidases Proteins 0.000 claims description 9
- 102000035195 Peptidases Human genes 0.000 claims description 8
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 6
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 230000001939 inductive effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 24
- 230000003020 moisturizing effect Effects 0.000 abstract description 12
- 230000001965 increasing effect Effects 0.000 abstract description 9
- 230000037384 skin absorption Effects 0.000 abstract description 8
- 231100000274 skin absorption Toxicity 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 5
- 230000001766 physiological effect Effects 0.000 abstract description 4
- 230000000774 hypoallergenic effect Effects 0.000 abstract description 2
- 235000010755 mineral Nutrition 0.000 description 53
- 210000003491 skin Anatomy 0.000 description 50
- 230000000052 comparative effect Effects 0.000 description 30
- 239000004615 ingredient Substances 0.000 description 16
- 238000010521 absorption reaction Methods 0.000 description 13
- 238000002845 discoloration Methods 0.000 description 12
- 230000008859 change Effects 0.000 description 9
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000002087 whitening effect Effects 0.000 description 5
- 239000013543 active substance Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 238000002481 ethanol extraction Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- -1 1.3-butylene glycol Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920001491 Lentinan Polymers 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000004098 cellular respiration Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940115286 lentinan Drugs 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000002352 surface water Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000222350 Pleurotus Species 0.000 description 1
- YUGCAAVRZWBXEQ-UHFFFAOYSA-N Precholecalciferol Natural products C=1CCC2(C)C(C(C)CCCC(C)C)CCC2C=1C=CC1=C(C)CCC(O)C1 YUGCAAVRZWBXEQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000238711 Pyroglyphidae Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 241000190021 Zelkova Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229940046533 house dust mites Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000001180 sulfating effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Cosmetics (AREA)
Abstract
본 발명에 따른 화장료 조성물은 해양심층수로부터 제조된 미네랄 농축수의 이온화 미네랄이 피부생리활성을 증가시키고 표고버섯 유용성분의 피부 흡수를 촉진하여 표고버섯의 생리활성 효능을 피부에 효율적으로 전달할 수 있으며, 또한 표고버섯을 가수분해하여 화장료 조성물에 함유시킴으로써 저자극이면서 보습 효과 등의 다양한 피부미용 효과를 제공하고 장기간 보관하여도 변질이 억제되므로 여러 제형의 화장료에 폭넓게 적용할 수 있다.
Description
구분 | 제조 직후 | 1 주 후 | 2 주 후 | 3 주 후 | 4 주 후 | |
실시예 | 5 ℃ | ○ | ○ | ○ | ○ | ○ |
25 ℃ | ○ | ○ | ○ | ○ | ○ | |
45 ℃ | ○ | ○ | ○ | ○ | ◑▣ | |
일광 | ○ | ○ | ○ | ○ | ◑ | |
비교예 1 | 5 ℃ | ○ | ○ | ○ | ○ | ◈ |
25 ℃ | ○ | ○ | ○ | ◈ | ◈◑ | |
45 ℃ | ○ | ○ | ○ | ◈◑▣ | ◆◑■ | |
일광 | ○ | ○ | ○ | ◈◑▣ | ◈◑▣ | |
비교예 2 | 5 ℃ | ○ | ○ | ○ | ○ | ○ |
25 ℃ | ○ | ○ | ○ | ○ | ◈ | |
45 ℃ | ○ | ○ | ○ | ◑▣ | ◈◑▣ | |
일광 | ○ | ○ | ○ | ◑ | ◈◑▣ | |
비교예 3 | 5 ℃ | ○ | ○ | ○ | ○ | ◈ |
25 ℃ | ○ | ○ | ○ | ○ | ◈◑ | |
45 ℃ | ○ | ○ | ◑ | ◑▣ | ◈◑▣ | |
일광 | ○ | ○ | ○ | ◑▣ | ◈◑■ | |
비교예 4 | 5 ℃ | ○ | ○ | ○ | ○ | ○ |
25 ℃ | ○ | ○ | ○ | ◑ | ◑▣ | |
45 ℃ | ○ | ○ | ◑▣ | ◑■ | ●■ | |
일광 | ○ | ○ | ◑▣ | ◑▣ | ◑■ | |
○:변화 없음, ◈:약한 층 분리, ◑:약한 변색, ▣:약한 변취, ◆:층 분리, ●:변색, ■:변취 |
구분 | 4 시간 | 8 시간 | 12 시간 | 24 시간 |
실시예 | 2.4 | 6.5 | 13.2 | 38.1 |
비교예 1 | 2.1 | 5.4 | 11.1 | 26.3 |
비교예 2 | 2.0 | 5.5 | 12.1 | 30.6 |
비교예 3 | 2.2 | 6.0 | 12.5 | 33.7 |
비교예 4 | 1.9 | 4.3 | 9.6 | 21.3 |
구분 | 2 분 | 4 분 | 6 분 | 8 분 | 10 분 |
실시예 | 79.2 | 71.4 | 63.7 | 50.3 | 39.5 |
비교예 1 | 76.1 | 61.8 | 48.2 | 36.5 | 25.4 |
비교예 2 | 77.6 | 68.4 | 58.3 | 45.2 | 31.5 |
비교예 3 | 78.3 | 70.2 | 61.7 | 47.4 | 34.5 |
비교예 4 | 76.2 | 62.5 | 49.4 | 37.8 | 27.9 |
Claims (6)
- 해양심층수를 건조하여 염도 5~9 %로 1차 농축하는 단계;
상기 1차 농축된 해양심층수를 자연증발시켜 염도 33~37 %로 2차 농축하는 단계;
상기 2차 농축된 해양심층수 중의 소금을 제거하고 가열하여 염도 38~42 %로 3차 농축하는 단계;
상기 3차 농축된 해양심층수를 활성탄에 통과시켜 음이온을 제거한 염도 33~37 %의 미네랄 농축수를 제조하는 단계;
표고버섯 분말 100 중량부에 상기 미네랄 농축수 1~5 중량부를 첨가하고 물을 혼합한 다음 60~80 ℃에서 3~5 시간 열수추출하여 1차 열수추출액을 제조하는 단계;
상기 1차 열수추출액 100 중량부에 단백질 분해효소 0.5~2.0 중량부를 첨가하고 60~80 ℃에서 3~5 시간 열수추출하여 2차 열수추출액을 제조하는 단계;
상기 2차 열수추출액 100 중량부에 에탄올 25~35 중량부를 혼합하여 정치한 후 에탄올과 침전물을 제거하여 표고버섯 추출액을 제조하는 단계; 및
상기 미네랄 농축수와 표고버섯 추출액을 혼합하는 단계;를 포함하는 화장료 조성물의 제조방법. - 청구항 1에 있어서,
상기 2차 농축하는 단계는, 1차 농축된 해양심층수(1)를 수용하는 수조(2), 상기 수조(2)의 해양심층수(1)를 건조틀(4)로 이송하는 펌프(3), 상기 수조(2)의 상부에 설치되고 펌프(3)로부터 인입되는 해양심층수를 천(5)에 분배하는 건조틀(4) 및 상기 건조틀(4)에 매달려 있고 건조틀(4)로부터 분배받은 해양심층수를 하부의 수조(2)로 흘러내리도록 유도하는 다수의 천(5)를 포함하는 자연증발장치(10)에서 이루어지는 것을 특징으로 하는 화장료 조성물의 제조방법. - 청구항 1에 있어서,
상기 활성탄은 5~15 mM 농도의 세틸피리디늄클로라이드 용액에 10~15 시간 동안 접촉시켜 개질한 활성탄인 것을 특징으로 하는 화장료 조성물의 제조방법. - 청구항 1에 있어서,
상기 에탄올과 침전물의 제거는 2차 열수추출액과 에탄올의 혼합액을 정치하여 상부의 에탄올, 중간의 표고버섯액, 하부의 침전물로 층분리시킨 다음 에탄올과 침전물을 제거하거나, 또는 혼합액을 가열하여 에탄올을 기화시켜 제거한 다음 정치하여 하부의 침전물을 제거하는 과정으로 이루어지는 것을 특징으로 하는 화장료 조성물의 제조방법. - 청구항 1에 있어서,
상기 혼합하는 단계는 표고버섯 추출액을 60~80 ℃에서 가열하여 5~10 Brix로 농축하고 물을 혼합하여 1~3 Brix로 희석한 후 미네랄 농축수 10~30 중량%와 상기 희석시킨 표고버섯 추출액 70~90 중량%를 혼합하는 과정으로 이루어지는 것을 특징으로 하는 화장료 조성물의 제조방법. - 청구항 1 내지 청구항 5 중 어느 한 항의 방법으로 제조되는 화장료 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190144547A KR102338400B1 (ko) | 2019-11-12 | 2019-11-12 | 해양심층수와 표고버섯 추출액을 유효성분으로 함유하는 화장료 조성물의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190144547A KR102338400B1 (ko) | 2019-11-12 | 2019-11-12 | 해양심층수와 표고버섯 추출액을 유효성분으로 함유하는 화장료 조성물의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210057596A true KR20210057596A (ko) | 2021-05-21 |
KR102338400B1 KR102338400B1 (ko) | 2021-12-10 |
Family
ID=76157703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190144547A KR102338400B1 (ko) | 2019-11-12 | 2019-11-12 | 해양심층수와 표고버섯 추출액을 유효성분으로 함유하는 화장료 조성물의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102338400B1 (ko) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002262820A (ja) * | 2001-03-07 | 2002-09-17 | Isao Horiuchi | きのこ類の有効成分の抽出方法 |
JP2004331467A (ja) * | 2003-05-09 | 2004-11-25 | Masahide Kawaguchi | 海水からの塩分濃縮方法、及びその濃縮装置並びにその方法を用いて得られた食塩 |
KR20140004576A (ko) * | 2012-07-03 | 2014-01-13 | 한국과학기술원 | 순환 공정이 가능한 독성 음이온의 제거 방법 |
KR20140010654A (ko) * | 2012-07-16 | 2014-01-27 | 주식회사 아리바이오 | 해양 심층수 또는 염지하수로부터 고경도의 미네랄 워터를 제조하는 방법 |
KR20150144039A (ko) * | 2014-06-16 | 2015-12-24 | 엠제이테크(주) | 용암 해수를 이용한 버섯 추출물을 함유하는 화장품 조성물 |
-
2019
- 2019-11-12 KR KR1020190144547A patent/KR102338400B1/ko active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002262820A (ja) * | 2001-03-07 | 2002-09-17 | Isao Horiuchi | きのこ類の有効成分の抽出方法 |
JP2004331467A (ja) * | 2003-05-09 | 2004-11-25 | Masahide Kawaguchi | 海水からの塩分濃縮方法、及びその濃縮装置並びにその方法を用いて得られた食塩 |
KR20140004576A (ko) * | 2012-07-03 | 2014-01-13 | 한국과학기술원 | 순환 공정이 가능한 독성 음이온의 제거 방법 |
KR20140010654A (ko) * | 2012-07-16 | 2014-01-27 | 주식회사 아리바이오 | 해양 심층수 또는 염지하수로부터 고경도의 미네랄 워터를 제조하는 방법 |
KR20150144039A (ko) * | 2014-06-16 | 2015-12-24 | 엠제이테크(주) | 용암 해수를 이용한 버섯 추출물을 함유하는 화장품 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR102338400B1 (ko) | 2021-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101460969B1 (ko) | 피부 화장료 조성물 | |
CN111281832B (zh) | 一种皮肤屏障修护复合物、化妆水及其制备方法 | |
CN104721129A (zh) | 微乳化生物科技护肤品 | |
CN107296764B (zh) | 膏霜及其制备方法 | |
CN107496245B (zh) | 一种抗衰老脂质体组合物及其制备方法和应用 | |
CN102908304A (zh) | 一种富含活性多肽的抗衰祛皱化妆水及其制备方法 | |
CN110236981A (zh) | 一种美白植物多糖组合物及其应用 | |
KR20190014477A (ko) | 은이 버섯 추출물, 이의 제조방법 및 이의 용도 | |
CN104958241A (zh) | 一种保湿中药面膜产品及其制备方法 | |
CN113368018A (zh) | 抗炎祛痘组合物及其制备方法 | |
CN109330954B (zh) | 美白亮肤水及其制备方法和酪氨酸酶抑制剂 | |
CN108852951B (zh) | 一种润肤洁肤组合物及植物沐浴露 | |
CN105726439B (zh) | 金蝉花美白保湿药妆品及其制备方法 | |
KR20100039532A (ko) | 아토피 치료용 하이드로겔 조성물 및 이를 매트릭스로 사용하는 아토피 치료용 매트릭스 패치 | |
CN104490713A (zh) | 一种具有排浊紧致和抗皱活化肌肤功能的超软活泉护肤品 | |
KR101142541B1 (ko) | 효소처리를 이용한 혼합생약재 추출물을 함유하는 피부 주름개선용 화장료 조성물 및 그 추출방법 | |
KR101474340B1 (ko) | 생약 발효 추출물을 포함하는 피부 노화 방지 화장료조성물 | |
CN112137919B (zh) | 竹荪蛋提取物在制备美容美肤外用品中的应用及基于其的美容外用品 | |
KR101370990B1 (ko) | 따나카 발효 추출물을 이용한 열노화 방지 및 피부 개선 조성물 | |
KR101662272B1 (ko) | 흑미의 배아와 미강 추출물 및 보리 추출물 혼합액을 유효성분으로 포함하는 화장료 조성물과 그의 제조방법 | |
CN102949328A (zh) | 一种具有抗衰祛皱和保湿补水功效的化妆水及其制备方法 | |
KR100812129B1 (ko) | 비타민 씨와 수용성 베타 글루칸을 함유하는피부노화방지용 화장료조성물 | |
KR102338400B1 (ko) | 해양심층수와 표고버섯 추출액을 유효성분으로 함유하는 화장료 조성물의 제조방법 | |
KR20180126912A (ko) | 용암해수 물티슈 조성물 | |
CN111053731A (zh) | 一种保湿爽肤水 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20191112 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20210419 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20211125 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20211207 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20211207 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |